<?xml version="1.0" encoding="UTF-8"?>
<results title="zoonosis">
 <result pre="the effects of convalescent plasma for the treatment of severe" exact="coronavirus disease 2019" post="(COVID-19). In addition to transfusion-related side effects, unexpected side"/>
 <result pre="efficacy of convalescent plasma therapy concurrently with its clinical use." exact="Coronavirus disease 2019" post="Severe acute respiratory syndrome coronavirus 2 COVID-19 serotherapy Plasma"/>
 <result pre="plasma therapy concurrently with its clinical use. Coronavirus disease 2019" exact="Severe acute respiratory syndrome" post="coronavirus 2 COVID-19 serotherapy Plasma Introduction Severe acute respiratory"/>
 <result pre="Severe acute respiratory syndrome coronavirus 2 COVID-19 serotherapy Plasma Introduction" exact="Severe acute respiratory syndrome" post="coronavirus 2 (SARS-CoV-2) infection has become a global concern,"/>
 <result pre="a global concern, and the World Health Organization (WHO) declared" exact="coronavirus disease 2019" post="(COVID-19) a Public Health Emergency of International Concern on"/>
 <result pre="syndrome coronavirus (SARS-CoV-1), and West Nile virus, and more recently," exact="Ebola" post="virus [789]. During the current COVID-19 pandemic, multiple studies"/>
 <result pre="viral load, serum cytokine response, and mortality. During the 2013" exact="Ebola" post="epidemic in West Africa, a nonrandomized study showed significantly"/>
 <result pre="who received standard treatment [13]. However, another nonrandomized study on" exact="Ebola" post="virus disease did not show the survival benefit of"/>
 <result pre="coronavirus diseases such as severe acute respiratory syndrome (SARS) and" exact="Middle East respiratory syndrome" post="(MERS). A study from a hospital in Hong Kong"/>
 <result pre="China Nonrandomized, non-controlled study 4 100% improved None [22] COVID-19," exact="coronavirus disease 2019." post="Although a recent systematic review showed uncertainty regarding the"/>
 <result pre="2GuanWJNiZYHuYLiangWHOuCQHeJXLiuLShanHLeiCLHuiDSCDuBLiLJZengGYuenKYChenRCTangCLWangTChenPYXiangJLiSYWangJLLiangZJPengYXWeiLLiuYHuYHPengPWangJMLiuJYChenZLiGZhengZJQiuSQLuoJYeCJZhuSYZhongNScollab: China Medical Treatment Expert Group for Covid-19Clinical characteristics of" exact="coronavirus disease 2019" post="in ChinaN Engl J Med20203821708172032109013 3KangSJJungSIAge-related morbidity and mortality"/>
 <result pre="de CastillaDFinbergRWDierbergKTapsonVHsiehLPattersonTFParedesRSweeneyDAShortWRTouloumiGLyeDCOhmagariNOhMDRuiz-PalaciosGMBenfieldTFÃ¤tkenheuerGKortepeterMGAtmarRLCreechCBLundgrenJBabikerAGPettSNeatonJDBurgessTHBonnettTGreenMMakowskiMOsinusiANayakSLaneHCcollab: ACTT-1 Study Group MembersRemdesivir for the treatment of" exact="Covid-19" post="- preliminary reportN Engl J Med2020NEJMoa2007764 6collab: RECOVERY Collaborative"/>
 <result pre="J Med2020NEJMoa2007764 6collab: RECOVERY Collaborative GroupHorbyPLimWSEmbersonJRMafhamMBellJLLinsellLStaplinNBrightlingCUstianowskiAElmahiEPrudonBGreenCFeltonTChadwickDRegeKFeganCChappellLCFaustSNJakiTJefferyKMontgomeryARowanKJuszczakEBaillieJKHaynesRLandrayMJDexamethasone in hospitalized patients with" exact="Covid-19" post="- preliminary reportN Engl J Med2020NEJMoa2021436 7Mair-JenkinsJSaavedra-CamposMBaillieJKClearyPKhawFMLimWSMakkiSRooneyKDNguyen-Van-TamJSBeckCRcollab: Convalescent Plasma"/>
 <result pre="infectionClin Infect Dis20115244745621248066 13SahrFAnsumanaRMassaquoiTAIdrissBRSesayFRLaminJMBakerSNicolSContonBJohnsonWAbiriOTKargboOKamaraPGobaARussellJBGevaoSMEvaluation of convalescent whole blood for treating" exact="Ebola" post="virus disease in Freetown, Sierra LeoneJ Infect20177430230927867062 14van GriensvenJEdwardsTde"/>
 <result pre="GriensvenJEdwardsTde LamballerieXSempleMGGallianPBaizeSHorbyPWRaoulHMagassoubaNAntierensALomasCFayeOSallAAFransenKBuyzeJRavinettoRTiberghienPClaeysYDe CropMLynenLBahEISmithPGDelamouADe WeggheleireAHabaNcollab: Ebola-Tx ConsortiumEvaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med2016374334226735992 15ChengYWongRSooYOWongWSLeeCKNgMHChanPWongKCLeungCBChengGUse of"/>
 <result pre="in patients with coronavirus disease 2019J Infect Dis2020222384332348485 25SalazarEPerezKKAshrafMChenJCastilloBChristensenPAEubankTBernardDWEagarTNLongSWSubediSOlsenRJLevequeCSchwartzMRDeyMChavez-EastCRogersJShehabeldinAJosephDWilliamsGThomasKMasudFTalleyCDlouhyKGLopezBVHamptonCLavinderJGolliharJDMaranhaoACIppolitoGCSaavedraMOCantuCCYerramilliPPruittLMusserJMTreatment of" exact="coronavirus disease 2019" post="(COVID-19) patients with convalescent plasmaAm J Pathol20201901680169032473109 26PerottiCBaldantiFBrunoRDel FanteCSeminariECasariSPercivalleEGlinganiCMusellaVBelliatoMGarutiMMeloniFFrigatoMDi"/>
 <result pre="SabatinoAKlersyCDe DonnoGFranchiniMCovid-19 plasma task force. Mortality reduction in 46 severe" exact="Covid-19" post="patients treated with hyperimmune plasma. A proof of concept"/>
</results>
